Title Category Credit Event date Cost
The Diagnostic Odyssey for Individuals With Rare Diseases: Pompe Disease and Other Lysosomal Storage Diseases
  • Disease Management
  • Health Equity
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • ASWB - Social Workers
$0.00 This activity will explore recent advances in the diagnosis and treatment of Pompe disease and other LSDs, including current clinical trials. It will also share insights and perspectives from and provide strategies to support the well-being of both the individual and their family/caregiver(s) and highlight the role of the interprofessional team in evaluating and improving care for patients with these conditions.
Integrating Care Teams in a Virtual World
  • Digital Health
  • Managed care
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • ASWB - Social Workers
$0.00 This activity will examine how the multiple aspects of digital health can be best utilized by health care team members to ensure continuity of the patient’s health care journey, meet care plan goals, improve patient outcomes and optimize team communication practices. The ability of virtual health care practices to enable team members to fulfill their roles in clinical decision-making and care plan implementation will be discussed. Important legal, regulatory and reimbursement considerations that pertain to digital practice integration within the health care team will be highlighted.
COVID-19 Vaccination Considerations Along the Transplant Continuum
  • Covid-19
  • Transplantation
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
  • ASWB - Social Workers
$0.00 This activity will review the current recommendations for screening and vaccination in both organ donors and organ recipients and will examine the current rationale and value of measuring COVID-19 antibody titers in light of possible low posttransplant sero-response and humoral response rates. Importantly, the current state of, and future implications for, transplantation in nonvaccinated patients will be discussed.
Precision Medicine: Expanding Opportunities
  • Disease Management
  • Oncology
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
  • ASWB - Social Workers
$0.00 This activty will discuss how precision medicine is quickly becoming a standard of care in the field of oncology and will explore recent advances in such applications as gene sequencing, molecular diagnostic assays, liquid biopsies and biomarkers. Future applications and innovations in precision medicine tailored to the treatment of specific cancers will also be examined.
Challenges and Considerations in Multi-organ Transplantation
  • Transplantation
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
  • ASWB - Social Workers
$0.00 Despite the large increase in the number of multi-organ transplants (MOTs) performed over the past few years, challenges still exist in this arena. Among these unresolved issues are a lack of standardized MOT eligibility criteria across institutions, regions and different organ combinations. Ethical issues have also arisen regarding equity in organ allocation amidst a limited organ supply, as many MOT candidates get priority allocation for nonprimary organs versus individuals requiring that organ as a single transplant; this prioritization may impact optimal recipient and graft survival as well. In this session, learn more about multi-organ allocation and its accompanying challenges, risks, benefits, and expected outcomes, as well as the limitations of MOT for potential recipients.
Posttransplant Diagnostics: Utilizing Biomarkers and Genomics to Optimize Immunosuppression and Reduce Complications
  • Disease Management
  • Transplantation
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
  • ASWB - Social Workers
$0.00 In this activity, participants will review conventional rejection-monitoring parameters and will identify current and emerging acute-rejection biomarkers. A closer look at data — regarding such biomarkers as donor-derived cell-free DNA, gene expression profiles, mRNA transcripts, immune effector pathway molecules, cell subsets and chemokines — will provide clarity about their predictive accuracy and value in rejection monitoring, as well as their ability to improve outcomes through rapid identification of transplant-organ dysfunction.
Updates on Xenotransplantation and the Artificial Kidney
  • Disease Management
  • Transplantation
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
  • ASWB - Social Workers
$0.00 Join this activity to discuss how technology to treat end-stage kidney failure has advanced in recent years, including a review of clinical trials of portable devices and implantable xenotransplants, and what the future holds for the next phase of investigation into the artificial kidney and xenotransplant.
Selecting Appropriate Treatments Based on Geriatric and Fragility Assessments
  • Disease Management
  • Oncology
  • Older Adults
  • Transplantation
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
  • ASWB - Social Workers
$0.00 This activity will provide an overview of geriatric and frailty assessment tools that can assist in guiding cancer- and transplant-related decision making through the risk stratification of older individuals before therapy is initiated. Data surrounding the relationship among increased age, geriatric- and frailty-assessment results, and disease outcomes will also be explored. Key considerations in how to best incorporate these sometimes time-intensive assessments into practice will be outlined, along with discussion of how interprofessional collaboration among members of the health care team in the creation of care plans can facilitate quality care.
Social Determinants of Health in Cancer Care
  • Disease Management
  • Health Equity
  • Oncology
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
  • ASWB - Social Workers
$0.00 This activity will review the impact of poorer SDOH status on cancer care, disease progression, outcomes, access to treatment and many other aspects. It will also present care models, strategies and resources to help health care professionals best confront the challenges faced by many individuals with cancer.
Implications for Transplantation in Acute-on-Chronic Liver Failure: Determining a Course of Action
  • Disease Management
  • Transplantation
  • ACPE - Pharmacists
  • ACPE - Pharmacy Technicians
  • AMA - Physicians
  • ANCC - Nurses
  • APA - Psychologists
  • Attendance - General Attendance
  • CCMC - General - Case Managers
  • CDR - Dietitians
  • ASWB - Social Workers
$0.00 This activity will help participants to better determine the role and optimal timing of liver transplant in ACLF. It will review precipitators of ACLF associated with poorer outcomes, including bacterial infections and hepatitis B virus, and will explore posttransplant outcomes and predictors. The accuracy of current scoring systems for assessing the severity of disease and predicting survival will be discussed, including the Model for End-stage Liver Disease (MELD) score and the Chronic Liver Failure Consortium Organ Failure (CLIF-C OF) score.

Pages